About Denexopharma
Denexopharma is a Healthcare company based in India. Wholesaler and trader of pharmaceutical injections, tablets, and capsules. It operates on a B2B model. Its Indian entity Denexo Pharmaceuticals Private Limited reported revenue of ₹42.9 Lakh. Denexopharma offers products and services including Pharmaceutical Injections, Pharmaceutical Tablets, Pharmaceutical Capsules, Tigecycline Injection, and Enoxaparin Injection. Its focus areas include Pharmaceuticals, Generic Drugs, Injections and Tablets.
Company details
Denexo Pharmaceuticals Private Limited, established in 2022, operates as a trader and wholesaler of various pharmaceutical products including injections, tablets, capsules, and related medical supplies. Based in Navi Mumbai, Maharashtra, India, they distribute these items to businesses in the healthcare sector, focusing on generic drugs and treatments. Their activities involve sourcing and supplying products for medical use, ensuring availability to distributors.
- Headquarters India
- Employees 1
- SectorsHealthcare
- Phone•••• ••••
- Website denexopharma.com
- Legal Name Denexo Pharmaceuticals Private Limited
- Date of Incorporation 20 Apr, 2022
- Jurisdiction Kharghar, Maharashtra, India
- Annual Revenue₹42.9 Lakh
FY 2025 · +4% YoY
- Net Profit₹16,000
FY 2025 · 0% margin
- EBITDA₹27,000
FY 2025 · 1% margin
- Employee Count1
Associated legal entities of Denexopharma
Denexopharma operates through Denexo Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Denexo Pharmaceuticals Private Limited CIN U51909MH2022PTC380935 | Active | 20 Apr 2022 | Kharghar, Maharashtra | ₹0.4 Cr | 2 | View details |
Products & Services of Denexopharma
Denexopharma offers a comprehensive portfolio of products and services, including Pharmaceutical Injections, Pharmaceutical Tablets, Pharmaceutical Capsules, Tigecycline Injection, and Enoxaparin Injection.
Injections for treatments like antibiotics and cancer therapy.
Tablets for conditions including antifungal and immunosuppressive uses.
Capsules for therapies such as tacrolimus-based immunosuppression.
Injection for bacterial infections and related treatments.
Injection for blood clot prevention and management.
Board of directors of Denexo Pharmaceuticals Private Limited (Denexopharma)
Denexo Pharmaceuticals Private Limited is the primary company behind Denexopharma. The board of Denexo Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Parul Singh, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Parul Singh DIN 09578360 | Director | 20 Apr 2022 | 4 yrs 6 mo | Denexo Pharmaceuticals Private Limited |
| Rachit Pratap Singh DIN 08995498 | Director | 20 Apr 2022 | 4 yrs 6 mo | Denexo Pharmaceuticals Private Limited |
Financials of Denexopharma
Figures of Denexo Pharmaceuticals Private Limited, the primary company behind Denexopharma, for FY 2025. Revenue was ₹42.9 Lakh (+4% year on year). Net profit was ₹16,000 (0% margin). EBITDA was ₹27,000 (1% margin).
- ₹42.9 LakhRevenue · FY 2025 · +4% YoY
- ₹16,000Net profit · 0% margin
- ₹27,000EBITDA · 1% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Denexo Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Denexopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Denexopharma
Denexopharma is headquartered in India.
Denexopharma has 1 employees.
The primary company behind Denexopharma, Denexo Pharmaceuticals Private Limited, reported revenue of ₹42.9 Lakh for FY 2025, up 4% year on year.
Denexo Pharmaceuticals Private Limited, established in 2022, operates as a trader and wholesaler of various pharmaceutical products including injections, tablets, capsules, and related medical supplies. Based in Navi Mumbai, Maharashtra, India, they distribute these items to businesses in the healthcare sector, focusing on generic drugs and treatments. Their activities involve sourcing and supplying products for medical use, ensuring availability to distributors.
Denexopharma offers Pharmaceutical Injections, Pharmaceutical Tablets, Pharmaceutical Capsules, Tigecycline Injection, and Enoxaparin Injection.
Denexopharma operates through Denexo Pharmaceuticals Private Limited.
The legal entities of Denexopharma currently have 2 directors, including Parul Singh, Rachit Pratap Singh.